{"entity":{"type":"insider","cik":"0001612861","url":"/insider/0001612861","json_url":"/insider/0001612861.json","name":"Robichaud Albert","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":8,"first":"2014-07-23","last":"2019-12-10","span_basis":"filed_date"},"name_variants":[{"name":"Robichaud Albert","source":"filing","n_filings":8,"first_seen":"2014-07-23","last_seen":"2019-12-10"}],"transactions":[{"id":8081970,"accession":"0001562180-19-005991","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-19-005991","line_url":"/filing/0001562180-19-005991#line-4","is_derivative":false,"issuer_cik":"0001597553","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001597553","owner_cik":"0001612861","owner_name":"Robichaud Albert","owner_display_name":"Robichaud Albert","owner_url":"/insider/0001612861","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":64.16,"price_display":"64.16","price_state":"stated","total_value":1604000.0,"total_display":"1,604,000.00","total_whole":"1,604,000","shares_owned_after":136400.0,"shares_owned_after_display":"136,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-10","scope":"insider"},{"id":4243960,"accession":"0001562180-17-003887","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001562180-17-003887","line_url":"/filing/0001562180-17-003887","is_derivative":false,"issuer_cik":"0001597553","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001597553","owner_cik":"0001612861","owner_name":"Robichaud Albert","owner_display_name":"Robichaud Albert","owner_url":"/insider/0001612861","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":159.4326135,"price_display":"159.43","price_state":"stated","total_value":9565956.81,"total_display":"9,565,956.81","total_whole":"9,565,957","shares_owned_after":102167.0,"shares_owned_after_display":"102,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-14","filed_date":"2017-12-14","scope":"insider","n_lines":8},{"id":2294908,"accession":"0001562180-16-002791","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-16-002791","line_url":"/filing/0001562180-16-002791#line-1","is_derivative":false,"issuer_cik":"0001597553","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001597553","owner_cik":"0001612861","owner_name":"Robichaud Albert","owner_display_name":"Robichaud Albert","owner_url":"/insider/0001612861","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22000.0,"shares_display":"22,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":880000.0,"total_display":"880,000.00","total_whole":"880,000","shares_owned_after":140222.0,"shares_owned_after_display":"140,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-12","filed_date":"2016-07-14","scope":"insider"},{"id":2224492,"accession":"0001562180-16-001395","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-16-001395","line_url":"/filing/0001562180-16-001395#line-1","is_derivative":false,"issuer_cik":"0001597553","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001597553","owner_cik":"0001612861","owner_name":"Robichaud Albert","owner_display_name":"Robichaud Albert","owner_url":"/insider/0001612861","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":40.02,"price_display":"40.02","price_state":"stated","total_value":800400.0,"total_display":"800,400.00","total_whole":"800,400","shares_owned_after":162222.0,"shares_owned_after_display":"162,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-25","filed_date":"2016-01-26","scope":"insider"},{"id":8510777,"accession":"0001562180-15-000635","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-15-000635","line_url":"/filing/0001562180-15-000635#line-1","is_derivative":false,"issuer_cik":"0001597553","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001597553","owner_cik":"0001612861","owner_name":"Robichaud Albert","owner_display_name":"Robichaud Albert","owner_url":"/insider/0001612861","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":67.06,"price_display":"67.06","price_state":"stated","total_value":804720.0,"total_display":"804,720.00","total_whole":"804,720","shares_owned_after":182222.0,"shares_owned_after_display":"182,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-03","filed_date":"2015-08-04","scope":"insider"},{"id":8834505,"accession":"0001562180-15-000551","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-15-000551","line_url":"/filing/0001562180-15-000551","is_derivative":false,"issuer_cik":"0001597553","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001597553","owner_cik":"0001612861","owner_name":"Robichaud Albert","owner_display_name":"Robichaud Albert","owner_url":"/insider/0001612861","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":72.134781875,"price_display":"72.13","price_state":"stated","total_value":1154156.51,"total_display":"1,154,156.51","total_whole":"1,154,157","shares_owned_after":200884.0,"shares_owned_after_display":"200,884","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-01","filed_date":"2015-07-01","scope":"insider","n_lines":3},{"id":8510761,"accession":"0001562180-15-000431","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-15-000431","line_url":"/filing/0001562180-15-000431","is_derivative":false,"issuer_cik":"0001597553","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001597553","owner_cik":"0001612861","owner_name":"Robichaud Albert","owner_display_name":"Robichaud Albert","owner_url":"/insider/0001612861","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":72.79591528125,"price_display":"72.80","price_state":"stated","total_value":1164734.6445,"total_display":"1,164,734.64","total_whole":"1,164,735","shares_owned_after":215653.0,"shares_owned_after_display":"215,653","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-02","scope":"insider","n_lines":4},{"id":6230578,"accession":"0001209191-14-048704","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-048704","line_url":"/filing/0001209191-14-048704#line-1","is_derivative":false,"issuer_cik":"0001597553","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001597553","owner_cik":"0001612861","owner_name":"Robichaud Albert","owner_display_name":"Robichaud Albert","owner_url":"/insider/0001612861","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":72000.0,"total_display":"72,000.00","total_whole":"72,000","shares_owned_after":226222.0,"shares_owned_after_display":"226,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-23","filed_date":"2014-07-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001597553","name":"Sage Therapeutics, Inc.","url":"/issuer/0001597553","role":"Officer (Chief Scientific Officer)","n_filings":8,"first_seen":"2014-07-23","last_seen":"2019-12-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001612861","retrieved_at":"2026-08-26T10:22:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}